Nuclear Radiology: Page 17

Navidea reclaims Lymphoseek distribution rights
By AuntMinnieEurope.com staff writers
Navidea Biopharmaceuticals has reclaimed marketing and distribution rights in Europe for its Lymphoseek radiopharmaceutical from Dutch pharmaceutical company Norgine.
May 10, 2020
ESMI honors Gambhir with achievement award
By AuntMinnieEurope.com staff writers
The European Society for Molecular Imaging (ESMI) has chosen Dr. Sanjiv Sam Gambhir, PhD, to receive its annual achievement award for 2020.
April 29, 2020
2020 04 29 22 54 0113 Trophy Award 400
IAEA acts to promote COVID-19 safety in nuclear medicine
By Wayne Forrest
New guidance from the International Atomic Energy Agency (IAEA) is designed to ensure that nuclear medicine departments across the globe keep patients and staff safe during the COVID-19 pandemic.
April 29, 2020
2020 04 28 15 13 5329 Iaea 400
Dutch airline makes pledge on radioisotope deliveries
By Wayne Forrest
KLM Royal Dutch Airlines has promised to allow medical isotopes to be carried on its planes from Europe to the U.S., beginning on 27 April. The move is designed to keep supplies moving during the COVID-19 pandemic.
April 23, 2020
2017 03 24 11 45 14 696 Dutch Flag 400
Blue Earth Diagnostics brings Axumin to Slovakia
By AuntMinnieEurope.com staff writers
Molecular imaging company Blue Earth Diagnostics has completed the first commercial delivery of its Axumin (fluciclovine F-18) PET radiopharmaceutical in Slovakia.
April 21, 2020
2020 04 22 18 47 9460 Business Men Handshake 400
U.K. staffing crisis deepens, RCR asserts
By Philip Ward
Workforce shortages in clinical radiology are increasing year-on-year, resulting in delayed diagnoses and lower-quality patient care, according to the latest annual census from the U.K. Royal College of Radiologists (RCR). Shortages of interventional and breast radiologists are an area of particular concern.
April 20, 2020
2019 11 01 16 57 7619 Ct Scan Patient 400
Incidental COVID-19 findings seen on routine FDG-PET/CT
By Wayne Forrest
Nuclear medicine practitioners should be prepared for incidental findings of COVID-19 when patients undergo FDG-PET/CT scans for routine oncologic indications, according to a study published online on 1 April in the Journal of Nuclear Medicine.
April 2, 2020
2020 04 02 22 53 2693 2020 04 02)covid 19 Fdg Pet Ct Jnm Albano Image G 400
Chinese team uses PET/CT on COVID-19 patients
By Wayne Forrest
Four patients with suspected COVID-19 underwent FDG-PET/CT at a Chinese hospital. The authors presented their findings online in the European Journal of Nuclear Medicine and Molecular Imaging on 25 March.
April 1, 2020
2020 02 12 18 38 0515 Virus Coronavirus2 400
IAEA publishes SPECT/CT usage guide
By AuntMinnieEurope.com staff writers
The International Atomic Energy Agency (IAEA) has published a quality control guide for SPECT/CT for nuclear medicine physicists, specialists, and radiation technologists.
March 29, 2020
2019 11 06 21 06 2992 Nuclear Medicine Gamma Camera 400
PET can help predict survival in prostate cancer
By Wayne Forrest
German and Swiss researchers have developed a PET-based risk classification metric for prostate cancer patients to help predict their survival without disease recurrence. They published their findings on 16 March in the European Journal of Nuclear Medicine and Molecular Imaging.
March 22, 2020
2016 10 04 11 38 34 158 Prostate 400
10 key actions to implement molecular radiotherapy
By Philip Ward
A European team of nuclear medicine specialists has proposed a 10-point plan to overcome the barriers to the clinical implementation of molecular radiotherapy. The plan was published online on 13 March by the European Journal of Nuclear Medicine and Molecular Imaging.
March 22, 2020
2020 03 20 17 20 3853 Cancer Radiotherapy 400
FDG-PET helps forecast outcome in neuroendocrine tumors
By Wayne Forrest
FDG-PET/CT can be used to classify neuroendocrine tumor patients into different prognostic categories for peptide receptor radionuclide therapy, German researchers have found. The decision to perform FDG-PET/CT should be based on the grading, time course of the disease, speed of progression, total tumor mass, and other criteria, they say.
March 19, 2020
2019 12 13 19 51 1879 Carcinoid Neuroendocrine Tumor 400
Previous Page
Page 17 of 90
Next Page